𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Can we really reduce the risk for prostate cancer?

✍ Scribed by Mitchell S. Steiner

Publisher
Springer-Verlag
Year
2003
Tongue
English
Weight
130 KB
Volume
21
Category
Article
ISSN
0724-4983

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effect of finasteride on risk of prostat
Effect of finasteride on risk of prostate cancer: How little we really know
✍ Mark A. Rubin; Philip W. Kantoff πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 233 KB

## Abstract The Prostate Cancer Prevention Trial (PCPT) reported conclusively that finasteride prevents or delays the detection of prostate cancer. One perplexing finding was that more high‐grade tumors were detected in the finasteride treated group. It is hard to put this into perspective because

Targeting prostate cancer for focal dest
Targeting prostate cancer for focal destruction : Can we find it?
✍ Samir S. Taneja; Basir Tareen πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 37 KB

With an increasing number of men diagnosed with low‐risk prostate cancer because of prostate‐specific antigen screening, there is growing focus on avoiding overtreatment by radical surgery or radiation. While focal destruction of prostate cancer is an appealing concept, it remains unclear whether cu

CA 50 Determination in body fluids: Can
CA 50 Determination in body fluids: Can we screen patients at risk for gastric cancer?
✍ F. Farinati; J. Holmgren; F. Di Mario; F. Cardin; F. Valiante; M. C. Fanton; G. πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 French βš– 588 KB

CA 50 (a tumor-associated gangliosidic antigen) levels have &en determined by an RIA test in serum, gastric juice and urine of patients undergoing upper gastrointestinal tract endoscopy: 22 control subjects (no macroscopic or microscopic lesions), 29 patients with chronic atrophic gastritis, 20 with